
Zenome is building a decentralized internet for genomic data and services, aiming to create a 'genomic Google' owned by the community. Their platform allows users to control and monetize their genetic data, making it available for scientific research and the development of new medicines. The system leverages blockchain technology for secure storage, exchange, and transparent transactions of genomic information, with an embedded economic model using internal cryptocurrency (ZNA). Zenome aims to become the premier infrastructure for the genomic internet, facilitating AI-driven advancements in medicine and personalized products.

Zenome is building a decentralized internet for genomic data and services, aiming to create a 'genomic Google' owned by the community. Their platform allows users to control and monetize their genetic data, making it available for scientific research and the development of new medicines. The system leverages blockchain technology for secure storage, exchange, and transparent transactions of genomic information, with an embedded economic model using internal cryptocurrency (ZNA). Zenome aims to become the premier infrastructure for the genomic internet, facilitating AI-driven advancements in medicine and personalized products.
What they do: Decentralized marketplace and platform for genomic data and services using blockchain and a native token
Founded: 2017
Location / industry: Moscow / Biotechnology
Team size (reported): ~7 employees
Known funding: Seed round (Nov 2018); reported total $812,000
Personal genomics data control, secure data exchange, and monetization for research and biotech development.
2017
Biotechnology
812000
“Sberbank-500 participated in or is listed in connection with seed funding”